These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24608234)

  • 21. Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.
    Muniyandi M; Ramachandran R
    Expert Opin Pharmacother; 2017 Sep; 18(13):1301-1309. PubMed ID: 28786691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcome of multidrug-resistant tuberculosis in Japan - the first cross-sectional study of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Izumi K; Ohkado A; Yoshiyama T
    BMC Infect Dis; 2018 Aug; 18(1):445. PubMed ID: 30170549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
    Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
    Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
    Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan.
    Lee PH; Chan PC; Peng YT; Chu PW; Wu MH; Jou R; Yu MC; Lin CJ; Huang YW; Chien ST; Lee JJ; Chiang CY
    PLoS One; 2019; 14(4):e0214792. PubMed ID: 30939150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study.
    Sharma N; Khanna A; Chandra S; Basu S; Chopra KK; Singla N; Babbar N; Kohli C
    Indian J Med Res; 2020 Jun; 151(6):598-603. PubMed ID: 32719234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
    Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
    Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitubercular drug resistance in four healthcare facilities in North India.
    Gupta A; Mathuria JP; Singh SK; Gulati AK; Anupurba S
    J Health Popul Nutr; 2011 Dec; 29(6):583-92. PubMed ID: 22283032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.
    Isaakidis P; Cox HS; Varghese B; Montaldo C; Da Silva E; Mansoor H; Ladomirska J; Sotgiu G; Migliori GB; Pontali E; Saranchuk P; Rodrigues C; Reid T
    PLoS One; 2011; 6(12):e28066. PubMed ID: 22145022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
    Denkinger CM; Pai M; Dowdy DW
    PLoS One; 2014; 9(1):e84197. PubMed ID: 24404155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
    Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India.
    Prakash R; Kumar D; Gupta VK; Jain S; Chauhan DS; Tiwari PK; Katoch VM
    J Infect Public Health; 2016; 9(3):289-97. PubMed ID: 26775848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for a case-control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India.
    Mistry N; Hemler EC; Dholakia Y; Bromage S; Shukla A; Dev P; Govekar L; Tipre P; Shah D; Keshavjee SA; Fawzi WW
    BMJ Open; 2020 Nov; 10(11):e039935. PubMed ID: 33184081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
    Tembo BP; Malangu NG
    BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.